SMTL ID : 5tkk.1

Structure of mouse vaccination-elicited HIV neutralizing antibody vFP5.01 in complex with HIV-1 fusion peptide residue 512-519

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.55 Å

Oligo State

hetero-1-1-mer

Ligands

1 x ALA- VAL- GLY- ILE- GLY- ALA- VAL- PHE: HIV-1 fusion peptide residue 512-519(Non-covalent)

ALA-VAL-GLY-ILE-GLY-ALA-VAL-PHE.1: 17 residues within 4Å: Chain A: A.32, Y.33, Y.34, Y.54, E.99, G.100, N.101, Y.102, R.103, A.104 Chain B: D.32, A.34, Y.49, Y.91, S.92, S.93, Y.94 20 PLIP interactions: 13 interactions with chain A, 7 interactions with chain B Hydrophobic interactions: A:A.32, A:Y.33, A:Y.34, A:Y.34, A:Y.54, A:E.99, A:A.104, B:A.34, B:Y.49, B:Y.91, B:Y.94 Hydrogen bonds: A:E.99, A:E.99, A:N.101, A:N.101, A:N.101, A:Y.102, B:D.32, B:Y.91, B:Y.94

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Xu, K. et al., Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1. Nat. Med. (2018)

Release Date

2018-04-04

Peptides

mouse antibody vFP5.01 heavy chain: A
mouse antibody vFP5.01 light chain: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
L

mouse antibody vFP5.01 heavy chain

mouse antibody vFP5.01 light chain